[1]Mclnnes IB, Kim HY, Lee SH, et al. Open-label tofaeitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study[J]. Ann Rheum Dis,2014, 73(1): 124-131.
[2]李自强,杜科伟,杜夏铭,等.椎体成形术与椎体后凸成形术治疗骨质疏松性椎体压缩性骨折发生骨水泥渗漏的相关临床评价[J].解放军医药杂志,2016,28(5):54-58.
[3]熊明月,刘立强,刘振辉,等.阿仑膦酸钠联合低分子肝素钙治疗老年骨质疏松性骨折的临床效果分析[J].中国生化药物杂志,2014(5):118-120.
[4]中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊治指南(2011年)[J].中华骨质疏松和骨矿盐疾病杂志,2011,4(1):2-17.
[5]张宏,任虎,冯涛,等.高粘度骨水泥椎体成形术与球囊扩张椎体成形术治疗骨质疏松性椎体压缩骨折疗效对比分析[J].解放军医药杂志,2016,28(6):62-65.
[6]Particelli F,Mecozzi L,Beraudi A. A comparison between micro-CT and histology for the evaluation of corical bone:effect of polymethylmethacrylate embedding on structural parameters[J].J Microsc,2012,245(3):302-310.
[7]方贺,何芳明,傅英华,等.阿仑膦酸钠治疗骨质疏松性脊柱压缩性骨折椎体成形术后残余疼痛的早期疗效观察[J].中国生化药物杂志,2015,35(10):35-37.
[8]杜宇康,廖瑛扬,肖淼盛,等.经皮椎体成形术与经皮椎体后突成形术治疗骨质疏松性椎体压缩骨折的疗效对比分析[J]. 中国矫形外科杂志,2014,22(10):946-948.
[9]Balkarli H, Demirtas H, Kilic M, et al. Treatment of osteoporotic vertebral compression fractures with percutaneous vertebroplasty under local anesthesia: clinical and radiological results [J]. Int J Clin Exp Med, 2015, 8 (9): 16287-16293.
[10]秦虎,何斌,王云华,等. 手法复位结合经皮椎体后凸成形术治疗老年新鲜骨质疏松性椎体压缩性骨折的研究[J].医学研究生学报,2015,28(4):385-389.
[11]张长春,朱坤,周建生,等. 经皮椎体成形术和经皮椎体后凸成形术治疗老年女性胸腰椎移行处单椎体骨质疏松性压缩性骨折对邻接椎体骨密度的影响[J].中国老年学杂志,2014,34(20):5741-5743.
[12]Balkarli H, Demirtas H, Kilic M, et al. Treatment of osteoporotic vertebral compression fractures with percutaneous vertebroplasty under local anesthesia clinical and radiological results[J]. Int J Clin Exp Med,2015,8(9): 16287-16293.
[13]包拥政,祝周兴,冯云升,等.低弹性模量骨水泥对骨质疏松压缩性骨折椎体及邻近椎体应力的影响:三维有限元分析[J].中国组织工程研究,2016,20(16):2285-2293.
[14]吴鹏,王博,孔令成,等.强骨饮颗粒联合阿仑膦酸钠维 D3片口服在原发性骨质疏松性髋部骨折术后抗骨质疏松治疗中的应用[J].中医正骨,2016,28(5):16-19.
[15]Zhang ZL,Liao EY,Xia WB,et al.Alendronate sodium/vitamin D3 combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women:a 6-month,randomized,open-label,active-comparator-controlled study with a6-month extension[J]. Osteoporos Int,2015,26(9):2365-2374.
[16]杨雪骅,陈志君,左权,等.阿仑膦酸钠、阿法骨化醇、碳酸钙联合应用治疗糖皮质激素诱发的骨质疏松症32例疗效分析[J].上海医药,2014,35(1):28-31.
[17]Khan A,Dubois S,Khan AA,et al.A randomized,doubleblind,placebo-controlled study to evaluate the effects of alendronate on bone mineral density and bone remodelling in perimenopausal women with low bone mineral density[J].J Obstet Gynaecol Can,2014, 36(11): 976-982.
[18]覃裕,邱冰,朱思刚,等.唑来膦酸与阿仑膦酸钠治疗骨质疏松患者的疗效比较及对血清25-(OH) D、BALP、BGP的影响分析[J].中国骨质疏松杂志,2016,22(8):1035-1038.
[19]Cosman F, Keaveny TM, Kopperdahl D, et al. Hip and spinestrength effects of adding versus switching to teriparatide in post-menopausal women with osteoporosis treated with prior alendr-onate or raloxifene [J]. J Bone Miner Res,2013,28(6): 1328-1336.
[20]Borromeo GL, Brand C, Clement JG, et al. A large case-controlstudy reveals a positive association between bisphosphonate useand delayed dental healing and osteonecrosis of the jaw[J].J Bone Miner Res, 2014, 29(6): 1363-1368.
[21]Muschitz C, Kocijan R, Fahrleitner-Pammer A, et al. Overlap-ping and continued alendronate or raloxifene administration in pa-tients on teriparatide: effects on areal and volumetric bone miner-al density-the CONFORS study [J]. J Bone Miner Res, 2014, 29(8): 1777-1785.